Effect of proteinuria and glomerular filtration rate on cardiovascular risk in essential hypertension  Julian Segura, Carlos Campo, Luis M. Ruilope  Kidney.

Slides:



Advertisements
Similar presentations
Volume 54, Pages S135-S139 (December 1998)
Advertisements

A.M. Thompson, T.G. Pickering  Kidney International 
Chronic Kidney Disease in Diabetes
Volume 67, Pages S1-S7 (June 2005)
Plasma sodium and hypertension
Diagnosis and Management of Chronic Kidney Disease
Management of hypertension in patients with chronic kidney disease
From secondary to primary prevention of progressive renal disease: The case for screening for albuminuria  Paul E. De Jong, Barry M. Brenner  Kidney International 
Chronic Kidney Disease in Diabetes
Prehypertension and chronic kidney disease: the ox or the plow?
Volume 80, Issue 10, Pages (November 2011)
Progression of renal failure and hypertensive nephrosclerosis
Volume 57, Issue 5, Pages (May 2000)
Corrections to "Estimating the glomerular filtration rate from serum creatinine is better than from cystatin C for evaluating risk factors associated.
John P. Middleton, Patrick H. Pun  Kidney International 
Volume 88, Issue 2, Pages (August 2015)
Volume 56, Issue 4, Pages (October 1999)
Homocysteine and risk in end-stage renal disease: a matter of context
Albuminuria as a predictor of cardiovascular and renal outcomes in people with known atherosclerotic cardiovascular disease  Johannes F.E. Mann, Qi-Long.
Volume 76, Issue 3, Pages (August 2009)
Anemia as a risk factor for chronic kidney disease
Volume 54, Issue 4, Pages (October 1998)
Comorbidity and confounding in end-stage renal disease
Volume 74, Issue 3, Pages (August 2008)
Volume 81, Issue 3, Pages (February 2012)
Volume 70, Issue 11, Pages (December 2006)
The epidemiology of chronic kidney disease
Volume 91, Issue 5, Pages (May 2017)
Study of Heart and Renal Protection (SHARP)
Volume 76, Issue 10, Pages (November 2009)
Volume 74, Issue 9, Pages (November 2008)
Acute myocardial infarction in patients with end-stage renal disease
Volume 67, Pages S48-S51 (January 2005)
Blood pressure targets in hemodialysis patients
Aggressive blood pressure reduction and renin–angiotensin system blockade in chronic kidney disease: time for re-evaluation?  Pantelis A. Sarafidis, Luis.
Fructose intake as a risk factor for kidney stone disease
Volume 73, Issue 12, Pages (June 2008)
Volume 85, Issue 3, Pages (March 2014)
Volume 74, Issue 4, Pages (August 2008)
Volume 82, Issue 7, Pages (October 2012)
Proteinuria and hypertensive nephrosclerosis in African Americans
Non-immunologic intervention in chronic allograft nephropathy
Methods for guideline development
Volume 87, Issue 1, Pages (January 2015)
The kidney, a cardiovascular risk marker, and a new target for therapy
Counteracting progression of renal disease: A look into the future
Volume 54, Pages S135-S139 (December 1998)
Volume 58, Issue 3, Pages (September 2000)
Homocysteine, renal function, and risk of cardiovascular disease
Yasunori Kitamoto, Katsuhiko Matsuo, Kimio Tomita  Kidney International 
Volume 64, Issue 2, Pages (August 2003)
ACE inhibition is effective and renoprotective in hypertensive nephrosclerosis: The African American Study of Kidney Disease and Hypertension (AASK) trial 
The course of the remnant kidney model in mice
Leileata M. Russo, Wayne D. Comper, Tanya M. Osicka 
Blood lead and chronic kidney disease in the general United States population: Results from NHANES III  Paul Muntner, Jiang He, Suma Vupputuri, Josef.
Volume 80, Issue 10, Pages (November 2011)
Michael R. Lattanzio, Matthew R. Weir  Kidney International 
Is it the low-protein diet or simply the salt restriction?
Cardiovascular risk in chronic kidney disease
Is complement a target for therapy in renal disease?
Areef Ishani, Allan J. Collins, Charles A. Herzog, Robert N. Foley 
Importance of blood pressure control in hemodialysis patient survival
Giuseppe Remuzzi, Carlos Chiurchiu, Piero Ruggenenti 
Volume 64, Issue 4, Pages (October 2003)
Volume 61, Issue 1, Pages (January 2002)
Volume 53, Issue 5, Pages (May 1998)
Volume 73, Issue 11, Pages (June 2008)
Kidney and hypertension
Volume 57, Pages S44-S48 (April 2000)
Antonio Piccoli, Luana Pillon  Kidney International 
Presentation transcript:

Effect of proteinuria and glomerular filtration rate on cardiovascular risk in essential hypertension  Julian Segura, Carlos Campo, Luis M. Ruilope  Kidney International  Volume 66, Pages S45-S49 (November 2004) DOI: 10.1111/j.1523-1755.2004.09212.x Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 1 INSIGHT study showed that proteinuria is a very powerful cardiovascular risk predictor, as an elevated serum creatinine or the existence of a previous myocardial infarction. Abbreviations: MI, myocardial infarction; HTN, hypertension; TOD, target organ damage; HLP, hyperlipidemia; SBP, systolic blood pressure; DBP, diastolic blood pressure. Kidney International 2004 66, S45-S49DOI: (10.1111/j.1523-1755.2004.09212.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 2 Relationship among severity of hypertension, cardiovascular and renal risk, and the presence of chronic kidney disease and increased urinary albumin excretion. Kidney International 2004 66, S45-S49DOI: (10.1111/j.1523-1755.2004.09212.x) Copyright © 2004 International Society of Nephrology Terms and Conditions